SM

Sreenivasasetty Madanur Gundappasetty

Director Director DIN 07759901
DIN 07759901 First appointment Mar 2017 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Mar 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Sreenivasasetty Madanur Gundappasetty

Data last updated:

Sreenivasasetty Madanur Gundappasetty was a Director at Samskruthy Pharma Private Limited (2017–2022). The company operates in Pharma.

DIN 07759901
Primary Designation Director
Industry Pharma
First Appointment 28 Mar 2017

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Samskruthy Pharma Private Limited U51909KA2017PTC101764
Director28 Mar 20172017₹6.82 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Samskruthy Pharma Private Limited
Premium access

Shareholding and investment profile for Sreenivasasetty Madanur Gundappasetty

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sreenivasasetty Madanur Gundappasetty

Sreenivasasetty Madanur Gundappasetty was first appointed on 28 Mar 2017 as Director at Samskruthy Pharma Private Limited.

Sreenivasasetty Madanur Gundappasetty held 1 earlier board appointment: Samskruthy Pharma Private Limited (Director, 28 Mar 2017 to 22 Jul 2022).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available